Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by World Top Scientists

Prof. Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

department leader at West Anhui University, China

Professor Chen, born in September 1972 in Jinzhai County, Anhui Province, is a distinguished scholar and a leading figure in the field of traditional Chinese medicine and natural product research. Currently, he serves as a Distinguished Professor (Dabieshan Scholar) at West Anhui University, where he also holds multiple leadership roles, including Deputy Director of the Experimental Teaching and Training Management Department, and Director of the Postdoctoral Research Workstation. He is a doctoral supervisor affiliated with Anhui University of Chinese Medicine and Anhui Agricultural University, and leads the Anhui Provincial Key Laboratory of Traditional Chinese Medicine Quality Evaluation and Enhancement. Prof. Chen is also the head of several strategic research teams and innovation platforms that focus on the modernization and industrialization of herbal medicine. A nationally recognized talent under the Anhui Provincial Special Support Plan, he has been honored as a Top Talent of Lu’an City, Outstanding Teaching Faculty of West Anhui University, and nominee for Lu’an Distinguished Talent Award. His scholarly influence is reinforced by his role as a reviewer for the National Natural Science Foundation and active participation in national academic societies, contributing to both academic and practical advancements in pharmaceutical science.

Professional Profile

Education

Professor Chen holds a PhD in Pharmaceutical Sciences, which provided the foundation for his career-long dedication to the research and development of traditional Chinese medicine. With a strong academic background rooted in pharmacy, chemistry, and biotechnology, his educational journey integrated classical medicinal knowledge with modern scientific methodology. Over the years, he has further enhanced his qualifications through postdoctoral research and continuous academic training, establishing himself as a multidisciplinary expert. His early education fostered a strong commitment to scientific excellence and innovation, particularly in areas such as medicinal chemistry, pharmacology, and natural product extraction. His academic milestones have been complemented by hands-on experience in laboratory work, clinical trials, and academic leadership. Prof. Chen’s teaching and mentorship roles at institutions such as Anhui University of Chinese Medicine and Anhui Agricultural University reflect a solid academic lineage and dedication to nurturing the next generation of researchers. His consistent academic growth, paired with strategic collaboration with scientific institutions, has enabled him to contribute meaningfully to the evolving landscape of pharmaceutical education in China. His educational achievements form the intellectual backbone of his extensive work in TCM standardization, drug development, and plant-based biomedicine.

Professional Experience

Throughout his career, Professor Chen has accumulated a wealth of professional experience spanning academia, research administration, and national-level scientific leadership. As a Professor at West Anhui University, he has played a pivotal role in curriculum development, talent cultivation, and institutional research strategy. He concurrently serves as Vice Secretary of the Party Committee and Deputy Director of the Experimental Training Management Department, while also leading the Postdoctoral Workstation and provincial laboratories in quality enhancement of traditional Chinese medicine. Prof. Chen is the Chief Investigator and Team Leader of several key innovation teams focused on medicinal plant research and pharmacological innovation. Beyond his university, he is deeply involved in provincial and national science policymaking, contributing as a Communications Reviewer for NSFC, and as a standing member of the Chinese Under-Forest Economy Society and Anhui Botanical Society. Over the years, he has led or participated in over 20 major scientific research projects, with total funding in the multimillion-yuan range. His work often bridges the gap between academia and industry, evidenced by extensive industry-academic collaboration, numerous patents, and standard-setting activities. His experience reflects a mature balance of teaching, research, and service that defines his leadership in Chinese pharmaceutical sciences.

Research Interests

Professor Chen research interests center on the quality evaluation, efficacy enhancement, and innovation of traditional Chinese medicines (TCMs). A key focus of his work is the phytochemistry, pharmacokinetics, and bioactivity of medicinal herbs, particularly Dendrobium huoshanense, a rare and valuable plant species. His investigations delve into metabolomics, network pharmacology, and structure-activity relationships, aiming to improve standardization and therapeutic potential of herbal products. He has also led efforts to decode the geographical specificity (daodi) and biological transformation mechanisms of active components in medicinal plants. His interest in synergistic fermentation, antioxidant activity, and enzyme inhibition studies has resulted in innovative methods for improving bioavailability and therapeutic outcomes of plant-based compounds. Additionally, Professor Chen integrates modern analytical technologies such as UPLC-MS/MS, NIR spectroscopy, and bioinformatics into his research toolkit, enhancing the precision and scalability of TCM research. His collaborative work with pharmaceutical companies aims to commercialize novel herbal formulations and functional health products. As TCM gains global interest, Prof. Chen’s research aligns with the trend of merging traditional knowledge with cutting-edge biomedical science, addressing critical issues in herbal medicine safety, efficacy, and modernization.

Awards and Honors

Professor Chen has been recognized with numerous prestigious awards and honors, reflecting his profound impact on pharmaceutical research and education. Among his most notable achievements are two Second Prizes for Science and Technology Progress in Anhui Province and the Special Award for Technological Advancement by the China General Chamber of Commerce. These accolades signify his contributions to both fundamental science and its practical application in the modernization of traditional Chinese medicine. He was also honored with the Anhui Provincial Teaching Achievement Award (Second Prize), highlighting his role in academic innovation and pedagogy. As a recipient of the Anhui Provincial Leading Talent under the Special Support Plan, Prof. Chen is acknowledged as a strategic scientific leader. He has been awarded Top Talent and Outstanding Scholar titles in Lu’an City, and recognized as a Teaching Master at West Anhui University. His selection as Principal Investigator for National Natural Science Foundation of China (NSFC) projects further underscores his status in China’s scientific community. With over 40 patent applications, 23 industry and local standards developed, and extensive mentorship roles, his accolades are both deep and diverse. These honors confirm his legacy as a highly influential and respected figure in biomedical and TCM research.

Conclusion

Professor 陈乃东 is a highly suitable candidate for the Best Researcher Award. His outstanding achievements in TCM quality research, natural products pharmacology, and regional development through science and innovation reflect the hallmarks of a leading researcher. His contributions are scientifically rigorous, socially relevant, and academically influential. With minor enhancements in global engagement and innovation translation, his profile could further stand out on the world stage.

Publications Top Notes

  • Author(s): Hao, Jingwen; Wang, Weiting; Chen, Naidong; Shen, Yan
    Year: 2025
    Title: Identification of 13 natural antioxidants in green calyx plum using AAPH, ABTS, and FRAP-coupled HPLC-DAD via QTOF-MS/MS
    Journal: Food Chemistry
    Citations: 0

  • Author(s): Chen, Naidong
    Year: 2025
    Title: Mechanism for the Inhibition of α-Glucosidase by Peptide Tyr-Pro-Ile-Trp (YPIW) and Its Stability
    Journal: Shipin Kexue / Food Science
    Citations: 0

  • Author(s): Zheng, Shaojun; Li, Sheng; Diao, Xiaohan; Chen, Naidong
    Year: 2025
    Title: Prunus mume Alleviates Hyperuricemic Renal Injury: Insights From Network Pharmacology and Experimental Models
    Journal: Biomedical Chromatography
    Citations: 0

  • Author(s): Hao, Kuku; Wang, Qijin; Wei, Shengxiang; Zheng, Shaojun; Zhang, Manman; Chen, Naidong (co-author)
    Year: 2025
    Title: Structural characterization and anti-inflammatory activity of a neutral polysaccharide from Dendrobium huoshanense C. Z. Tang et S. J. Cheng
    Journal: International Journal of Biological Macromolecules
    Citations: 0

  • Author(s): Hao, Jingwen; Fan, Xuanxuan; Chen, Naidong; Xiao, Jun; Zhang, Manman
    Year: 2025
    Title: A novel method for the simultaneous determination of flavonoids in Pteridium aquilinum via SPE combined with UPLC-DAD via QAMS
    Journal: Journal of Food Composition and Analysis
    Citations: 0

 

Shihab Uddin Ahmad | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by World Top Scientists

Shihab Uddin Ahmad | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at University of Asia Pacific, Bangladesh

Dr. Shihab Uddin Ahmad (RPh, PhD) is an accomplished academic and researcher specializing in pharmacology, drug discovery, and molecular biology. Currently serving as an Assistant Professor and Coordinator of the Master of Pharmacy in Clinical Pharmacy and Pharmacology Program at the University of Asia Pacific, Bangladesh, he has made significant contributions to natural product pharmacology and functional medicine. With a postdoctoral background from Shanghai Jiao Tong University, he has actively engaged in cutting-edge research, particularly in stem cell therapy, metabolic diseases, and pharmaceutical innovations. His expertise spans experimental pharmacology, biotechnology, and advanced drug delivery systems, with a strong emphasis on translational research. A prolific author and patent holder, Dr. Ahmad’s work has been recognized through numerous publications in high-impact journals. His dedication to academic excellence and research innovation positions him as a leader in the field of pharmaceutical sciences.

Professional Profile

Education

Dr. Ahmad holds a Doctor of Philosophy (Ph.D.) in Pharmacology from Universiti Kebangsaan Malaysia, where he focused on wound healing properties of medicinal plants. He earned his Master of Science in Pharmaceutical Technology (M. Pharm. Tech.) and Bachelor of Pharmacy (B. Pharm.) from the University of Asia Pacific, Bangladesh, demonstrating an early interest in drug formulation, bioactive compounds, and molecular pharmacology. His academic journey has been driven by a passion for pharmacological research and drug discovery, equipping him with extensive biomedical expertise. Through his education, he developed proficiency in biochemical and molecular techniques, tissue recombination assays, and computational drug analysis. His multidisciplinary training in pharmacology, biotechnology, and clinical pharmacy has enabled him to bridge the gap between traditional medicine and modern pharmaceutical innovations, fostering impactful research in phytomedicine and metabolic disorders.

Professional Experience

Dr. Ahmad has a diverse professional background, spanning academia, industry, and postdoctoral research. Currently, he serves as the Coordinator and Assistant Professor at the University of Asia Pacific, Bangladesh, where he oversees research and academic programs in clinical pharmacy and pharmacology. Previously, he was a Postdoctoral Fellow at Renji Hospital, Shanghai Jiao Tong University, China, where he worked on cancer research and stem cell-based therapies. His industry experience includes serving as a Scientific Program Coordinator and Senior Executive at Ibn-Sina Natural Medicine Division, focusing on herbal drug development and product management. Additionally, he worked in the pharmaceutical production sector, gaining hands-on expertise in drug formulation, quality control, and regulatory affairs. His combined experience in research, industry, and education makes him a well-rounded professional with a strong impact in the field of drug discovery and molecular pharmacology.

Research Interests

Dr. Ahmad’s research interests focus on natural product pharmacology, drug delivery technology, and molecular biology, particularly in the development of phytomedicines and nutraceuticals. His work explores metabolic disorders, including obesity, diabetes, fatty liver disease, and postmenopausal hormonal imbalances such as PCOS and osteoporosis. He has also contributed to cancer pharmacology, investigating novel anticancer compounds and nanoparticle-based drug delivery systems. His expertise extends to neurodegenerative diseases and tissue regeneration, utilizing CRISPR technology, stem cell research, and bioinformatics to advance therapeutic innovations. By integrating experimental pharmacology with computational analysis, he aims to bridge the gap between traditional medicine and modern drug development. His ongoing research projects involve nanomedicine, polymeric drug delivery, and personalized medicine, reflecting a multidisciplinary approach to pharmaceutical sciences.

Awards and Honors

Dr. Ahmad has received numerous awards and recognitions for his contributions to pharmaceutical sciences and biomedical research. He is a patent holder for an innovative wound healing medicament, showcasing his ability to translate research into real-world applications. His research projects have been supported by prestigious grants from institutions such as UAP, Dhaka University, and international funding agencies. He has been an invited speaker at scientific conferences and has received accolades for his publications in high-impact journals. His work in drug discovery and therapeutic innovations has positioned him as a leading researcher in phytomedicine and clinical pharmacology. With an impressive track record of scientific achievements, mentorship, and academic leadership, Dr. Ahmad continues to make significant contributions to the advancement of pharmaceutical and biomedical sciences.

Conclusion

Dr. Shihab Uddin Ahmad is a strong candidate for the Best Researcher Award due to his extensive research contributions, leadership, and innovation in pharmacology and drug discovery. His combination of academic excellence, technical expertise, and mentorship makes him well-deserving of recognition. While enhancing international collaboration and increasing high-impact publications would further strengthen his profile, his overall achievements position him as a highly competitive contender for the award.

Publications Top Noted

  • Network Pharmacology, Molecular Docking and Experimental Validation on Potential Application of Diabetic Wound Healing of Cinnamomum zeylanicum Through Matrix Metalloproteinases-8 And 9 (MMP-8 And MMP-9)

    • Authors: Akter, S., Ahmad, S., Bhuiyan, M., Dewan, I., Reza, R., Morshed, N., Samdani, M., Reza, M., Kumer, A., Mohamed, I. N.
    • Year: 2025
    • Journal: Drug Design, Development and Therapy
    • DOI: 10.2147/DDDT.S489113

  • Metformin Hydrochloride Loaded Mucoadhesive Microspheres and Nanoparticles for Anti-Hyperglycemic and Anticancer Effects Using Factorial Experimental Design

    • Authors: Kotha, A. A., Ahmad, S. U., Dewan, I., Bhuiyan, M., Rahman, F. I., Mohamed, I. N., Reza, M. S.
    • Year: 2023
    • Journal: Drug Design, Development and Therapy
    • DOI: 10.2147/dddt.s432790

  • Antidiabetic Effect of Actinodaphne angustifolia and Profiling of Bioactive Metabolites using UPLC-QToF/ESI-MS Method

  • Improvement of lipid profile and hepatic oxidative stress in high-fat-diet-induced hyperlipidemic Swiss albino rats by Piper betle juice: evidences from in vivo and in silico studies

    • Authors: Jing, X., Sarker, M. R., Gifari, A. J., Maruf, R. A., Alam, S., Khan, F., Soma, M. A., Hossain, S., Ming, L. C., Ahmad, S. U.
    • Year: 2022
    • Journal: Cellular and Molecular Biology
    • DOI: 10.14715/cmb/2022.68.9.1

  • A Dose Optimization Study of Marantodes pumilum (Blume) Kuntze Extracts for Wound Healing Effect in Animal Model

  • Evaluation of Wound-Healing and Antioxidant Effects of Marantodes pumilum (Blume) Kuntze in an Excision Wound Model

  • The Pharmacological Potential of Oil Palm Phenolics (OPP) Individual Components

    • Author: Ahmad, S. U.
    • Year: 2019
    • Journal: International Journal of Medical Sciences
    • DOI: 10.7150/ijms.29934

  • Novel Pharmacotherapeutic Approaches in Treatment of Alcohol Addiction

  • Antioxidant and Anti-inflammatory Activities of Marantodes pumilum (Blume) Kuntze and Their Relationship with the Phytochemical Content

  • Labisia pumila improves wound healing process in ovariectomized rat model

  • Phyto-estrogenic effects of Marantodes pumilum (Blume) kuntze syn. Labisia pumila (Blume) Fern.-Vill. for the prevention and treatment of post-menopausal diseases

    • Authors: Ahmad, S. U., Azam, A., Shuid, A. N., Mohamed, I. N.
    • Year: 2017
    • Journal: Indian Journal of Traditional Knowledge
    • EID: 2-s2.0-85011866753

 

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by World Top Scientists

Mrs. fangyan He | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, China

He Fangyan is a distinguished researcher specializing in the pharmacodynamics and pharmacokinetics of traditional Chinese medicine. Currently serving as a Senior Experimentalist at Yunnan University of Traditional Chinese Medicine, she has led multiple high-impact studies focusing on ischemic stroke mechanisms and brain pharmacokinetics. With a commitment to advancing neuropharmacology, she has secured prestigious research grants, contributed to key scientific advancements, and developed innovative methodologies in cerebral ischemia treatment. Her expertise extends to drug metabolism, blood-brain barrier protection, and targeted drug delivery, making her a prominent figure in the field. Through her patents, publications, and ongoing research, she continues to bridge the gap between traditional Chinese medicine and modern pharmacological science.

Professional Profile

Education

He Fangyan holds an advanced degree in pharmacology and traditional Chinese medicine research, equipping her with interdisciplinary expertise in both experimental and clinical pharmacokinetics. She has undergone rigorous training in drug absorption, metabolism, and pharmacodynamics, particularly focusing on ischemic stroke therapies. Her academic background includes specialized studies in cerebral ischemia-reperfusion injury and neuroprotection, which laid the foundation for her innovative research contributions. She has further enhanced her knowledge through postgraduate research projects, technical training in pharmacological analysis, and collaborations with leading scientists in neurological drug development. Her education has provided her with a strong analytical and methodological foundation, enabling her to conduct cutting-edge research in traditional Chinese medicine’s role in stroke management.

Professional Experience

With extensive experience in experimental pharmacology and neuroscience, He Fangyan has held a senior research position at Yunnan University of Traditional Chinese Medicine, leading multiple research projects funded by national and provincial grants. She has played a pivotal role in advancing traditional Chinese medicine applications for stroke treatment, particularly through the study of Gastrodia’s neuroprotective effects. Over the years, she has worked on high-impact studies integrating brain microdialysis, PK/PD modeling, and oxidative stress mechanisms. In addition to academic research, she has contributed to methodology development in neuropharmacology, ensuring precise drug targeting and evaluation of traditional medicine compounds. Her professional contributions also extend to mentoring young researchers and fostering interdisciplinary collaborations, strengthening the field of pharmacokinetics and neuroprotection.

Research Interests

He Fangyan’s primary research interests revolve around cerebral ischemia, blood-brain barrier protection, and pharmacokinetics of traditional Chinese medicine compounds. She is particularly focused on understanding the mechanisms of ischemic stroke and the therapeutic potential of Gastrodia-derived compounds in treating oxidative stress-induced brain damage. Her studies employ microdialysis techniques, drug metabolism analysis, and neuroprotective compound development, making significant contributions to stroke research. She is also deeply invested in the translation of traditional Chinese medicine principles into modern pharmacological applications, aiming to bridge ancient remedies with contemporary scientific methodologies. Additionally, she explores novel drug delivery systems and prodrug mechanisms, ensuring targeted treatment with minimal side effects for cerebrovascular diseases.

Awards and Honors

He Fangyan has been recognized for her outstanding contributions to traditional Chinese medicine research and neuropharmacology. She has received funding from prestigious institutions such as the National Natural Science Foundation of China and the Yunnan Science and Technology Department, reflecting the significance of her work. Her patented innovations in cerebral ischemia treatment have earned acclaim, contributing to advancements in stroke therapy. She has also published extensively in SCI-indexed journals, further solidifying her academic reputation. As a key figure in pharmacokinetics and stroke research, she has been invited to speak at academic conferences and collaborate on national research initiatives. Her dedication to scientific progress and innovation continues to garner recognition, positioning her as a leading researcher in the field of traditional Chinese medicine and neuroscience.

Conclusion

He Fangyan is a strong candidate for the Best Researcher Award due to extensive contributions to pharmacokinetics and stroke research, significant grant funding, patents, and high-impact journal publications. Strengthening industry ties, international collaborations, and academic outreach could further solidify eligibility for top-tier research awards.

Publications Top Noted

  • He, F., Feng, J., Sun, H., Xu, Y., Yan, H., Song, X., Wang, Y., Li, X., & Lin, Q. (2024). Protective Effect of Protocatechuic Aldehyde on Cerebral Ischemia/Reperfusion Injury in Rats through Blood–Brain Barrier Protection. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-024-06264-z

  • He, F., Xu, C., Feng, J., Sun, H., Yan, M., Yang, Q., Zhou, X., Yang, J., & Lin, Q. (2024). Pharmacokinetics of 4-Hydroxybenzaldehyde in Normal and Cerebral Ischemia–Reperfusion Injury Rats Based on Microdialysis Technique. European Journal of Drug Metabolism and Pharmacokinetics. https://doi.org/10.1007/s13318-023-00863-3

  • He, F., Ma, C., Feng, J., Li, X., Xia, S., Lin, Q., Dai, R., & He, F. (2021). Angiogenesis effects of 4-methoxy benzyl alcohol on cerebral ischemia-reperfusion injury via regulation of VEGF-Ang/Tie2 balance. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2021-0118

  • He, F., Dai, R., Zhou, X., Li, X., Song, X., Yan, H., Meng, Q., Yang, C., & Lin, Q. (2019). Protective effect of 4-Methoxy benzyl alcohol on the neurovascular unit after cerebral ischemia reperfusion injury. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2019.109260

  • He, F., Duan, X., Dai, R., Li, Y., & Lin, Q. (2017). Protective Effect of 4-Methoxy Benzyl Alcohol on the Blood–Brain Barrier after Cerebral Ischemia Reperfusion Injury. Journal of Stroke and Cerebrovascular Diseases. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.01.018